Posts
$GALT - Galectin Therapeutics: FDA cleared a single-trial path to approval. The company can't afford to run it.
Galectin Therapeutics (GALT) is a clinical-stage biotech with one drug, belapectin, for MASH cirrhosis with portal hypertension (severe liver scarring plus dangerous high blood pressure in the liver's veins). Stock jumped over 25% on June 24 after the company announced that the FDA had agreed on the design for a …
The Lounge
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
$NIXX $1B Reverse Merger Giving Double-Digit Trades, Triple-Digit Swing Potential
Updating these guys bc good things have continued to happen here. After several legacy business divestitures, these guys just sort of languished in obscurity for months. They had narrowed their focus to telecom and data infrastructure and were building an automated AI communications platform to scale global voice and messaging …
New 66.2m @ 6.57 g/t Au at NE Tyro looks interesting from $WPG
Fresh drill results from West Point Gold ($WPG / $WPGCF) stood out in stock exchange releases. \* Hole GC26-148 at the Northeast Tyro zone on the Gold Chain Project intersected 66.2 meters of 6.57 grams per ton of gold including 20.7 meters of 18.25 grams per ton of gold. This …
Finding value where others aren't looking - Auxly Cannabis
Ticker in Canada is XLY.TO USA is CBWTF All numbers in CAD This isn't really meant to be a yolo/quick flip, not that it couldn't be. I'm planning on holding 5+ years I've been invested in Auxly Cannabis for the last couple years with a current average cost basis of …
Real talk: What is the most brutal lesson you’ve learned trading penny stocks that you wish you knew on day one?
We’ve all paid our "market tuition" at some point. Whether it was holding through a massive pump only to become a long-term bagholder, completely ignoring stop-losses, or blindly trusting a random Reddit DD without doing your own research. If you could give one piece of actual, realistic advice to someone …
NovaRed adds advisory firepower as critical minerals get more political
CSE: NRED added Katie Zacharia to its advisory board, and I think the appointment fits the direction critical minerals are moving. This is not a geology update. It is not a drill result, resource estimate or financing. The core company story is still Wilmac first. Wilmac is a 16,078-hectare copper-gold …
Tracking infrastructure capex shifts beyond primary compute
The recent downside pressure across the Nаsdaq Composite and S&P 500 highlights a broader reallocation of capital away from overextended semiconductor valuations. As major hardware layers like Nvidia, Micron, and AMD underperform due to concerns regarding capital expenditure sustainability and infrastructure debt loads, it is worth monitoring how institutional allocation …
CleanTech Vanadium ($CTV.V / $CTVFF): A Fluorspar Play Tied to AI Infrastructure?
I’ve been researching fluorspar recently and came across CleanTech Vanadium. The company is advancing fluorspar projects in the Illinois-Kentucky Fluorspar District (IKFD), historically the source of most U.S. fluorspar production. A few things that caught my attention: • Fluorspar is the primary commercial source of fluorine • Fluorine is required …
$ENTX - Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis (NASDAQ: ENTX)
***Seem Interesting -*** Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis (NASDAQ: ENTX). ***The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total …